OPRM1 and neoplasm: However, we could speculate that a dysregulated MOR turnover in malignant cells as the result of an inflammatory tumor microenvironment could explain our findings in which sustain stimulation with an agonist (opioid) impairs receptor desensitization, internalization, and down-regulation (18).